Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Mol Cancer. 2020 May 20;19(1):93. doi: 10.1186/s12943-020-01214-5.

¹ Division of Cancer Biology, Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA.
² Institute for Systems Biology, Seattle, WA, 98109, USA.
³ Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Internal Medicine, Holden Comprehensive Cancer Center, University of Iowa Carver College of Medicine, Iowa City, IA, 52242, USA.
⁴ Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA.
⁵ Department of Pathology and Laboratory Medicine, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA.
⁶ Division of Cancer Biology, Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA, 30322, USA. xdeng4@emory.edu.

Abstract

An amendment to this paper has been published and can be accessed via the original article.